Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Expanded access fingolimod study for multiple sclerosis patients completing phase IIIb studies in Italy
2012-005507-40Phase 3Terminated
- Sponsor
- Novartis
- Start
- Feb 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of fingolimod in multiple sclerosis (MS), sponsored by Novartis. Started Feb 2013; status: terminated.
02
Drugs
fingolimod
03
Conditions
multiple sclerosis (MS)
Beyond the preview
Go deeper on 2012-005507-40.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-005507-40.